LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 7 of 166
Next
>>
>
151 to 175 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Relative Growth Rate After Treatment
BT-20	CP724714	0.12	uM	LJP5	72	hr	1097	3658	3769	0.9706	0.9585
BT-20	CP466722	0.12	uM	LJP5	72	hr	1097	4048	3769	1.0740	1.1045
BT-20	Crizotinib	0.12	uM	LJP5	72	hr	1097	3563	3769	0.9452	0.9227
BT-20	Momelotinib	0.12	uM	LJP5	72	hr	1097	3476	3769	0.9223	0.8904
BT-20	Dasatinib	0.12	uM	LJP5	72	hr	1097	2306	3769	0.6118	0.4525
BT-20	Dasatinib	0.12	uM	LJP6	72	hr	1097	1455	3769	0.3862	0.1341
BT-20	Dovitinib	0.12	uM	LJP5	72	hr	1097	2546	3769	0.6754	0.5421
BT-20	Enzastaurin	0.12	uM	LJP5	72	hr	1097	4042	3769	1.0723	1.1020
BT-20	Erlotinib	0.12	uM	LJP5	72	hr	1097	3281	3769	0.8704	0.8172
BT-20	Foretinib	0.12	uM	LJP5	72	hr	1097	3635	3769	0.9643	0.9497
BT-20	R406	0.12	uM	LJP6	72	hr	1097	3598	3769	0.9547	0.9361
BT-20	Pictilisib	0.12	uM	LJP6	72	hr	1097	2576	3769	0.6836	0.5536
BT-20	Gefitinib	0.12	uM	LJP6	72	hr	1097	3197	3769	0.8481	0.7858
BT-20	Geldanamycin	0.12	uM	LJP5	72	hr	1097	1238	3769	0.3285	0.0528
BT-20	Geldanamycin	0.12	uM	LJP6	72	hr	1097	1049	3769	0.2785	-0.0178
BT-20	GSK1059615	0.12	uM	LJP5	72	hr	1097	2863	3769	0.7595	0.6608
BT-20	GSK1059615	0.12	uM	LJP6	72	hr	1097	2383	3769	0.6322	0.4811
BT-20	GSK1904529A	0.12	uM	LJP6	72	hr	1097	3289	3769	0.8725	0.8202
BT-20	Omipalisib	0.12	uM	LJP6	72	hr	1097	729	3769	0.1934	-0.1378
BT-20	GSK 690693	0.12	uM	LJP5	72	hr	1097	2905	3769	0.7708	0.6767
BT-20	GW843682X	0.12	uM	LJP6	72	hr	1097	2174	3769	0.5768	0.4031
BT-20	HG-5-113-01	0.12	uM	LJP5	72	hr	1097	3485	3769	0.9245	0.8935
BT-20	HG-5-88-01	0.12	uM	LJP6	72	hr	1097	3491	3769	0.9263	0.8960
BT-20	Imatinib	0.12	uM	LJP6	72	hr	1097	3779	3769	1.0026	1.0037
BT-20	JNK-9L	0.12	uM	LJP6	72	hr	1097	2972	3769	0.7884	0.7016

|<
<<
Previous
Page 7 of 166
Next
>>
>
151 to 175 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)